| Identification | Back Directory | [Name]
Milfasartan | [CAS]
148564-47-0 | [Synonyms]
Milfasartan
Unii-8ual5421cl
Milfasartan [inn]
Methyl 2-((4-butyl-2-methyl-6-oxo-5-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-1(6H)-pyrimidinyl)methyl)-3-thiophenecarboxylate
methyl 2-[[4-butyl-2-methyl-6-oxo-5-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-1-yl]methyl]thiophene-3-carboxylate
3-Thiophenecarboxylic acid, 2-[[4-butyl-2-methyl-6-oxo-5-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1(6H)-pyrimidinyl]methyl]-, methyl ester | [Molecular Formula]
C30H30N6O3S | [MDL Number]
MFCD00931662 | [MOL File]
148564-47-0.mol | [Molecular Weight]
554.66 |
| Hazard Information | Back Directory | [Uses]
Milfasartan (LR-B/081) is a selective angiotensin receptor AT1 antagonist with antihypertensive activity[1]. | [References]
[1] Grange RL, et al. Selenosartans: novel selenophene analogues of milfasartan and eprosartan. Bioorg Med Chem Lett. 2008 Feb 1;18(3):1241-4. DOI:10.1016/j.bmcl.2007.11.136 |
|
|